Decision looms that could determine fate of Alzheimer’s drug

>> Pam Belluck, The New York Times
02:25 02:25 PM BdST
Henry Magendantz, a participant in the Aduhelm clinical trial, finishes receiving an infusion of the drug at Butler Hospital in Providence, RI, May 27, 2021. Medicare officials are trying to determine whether to cover Aduhelm, which the FDA approved despite unclear evidence that it helps patients.

Read the source article at bdnews24.com
2022-01-01 10:25:00